Evidence map›Paper›PMID 23326246›Full record

ArticlePLoS genetics2013

Genome-wide screens for in vivo Tinman binding sites identify cardiac enhancers with diverse functional architectures.

Hong Jin, Robert Stojnic, Boris Adryan, Anil Ozdemir, Angelike Stathopoulos, Manfred Frasch

Abstract read
In one paragraph

Article in PLoS genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. The Roles of the LIM Domain Proteins inFrontiers in cardiovascular medicine · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. In Vivo Imaging of Muscle-tendon Morphogenesis in Drosophila Pupae.Journal of visualized experiments : JoVE · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Genome-Wide Approaches to Drosophila Heart Development.Journal of cardiovascular development and disease · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hong JinDepartment of Biology, Division of Developmental Biology, University of Erlangen-Nuremberg, Erlangen, Germany.
Robert Stojnic
Boris Adryan
Anil Ozdemir
Angelike Stathopoulos
Manfred Frasch

Funding

Patterning of Drosphila Embryos by the Dorsal-dependent Gene NetworkR01GM077668 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI STATHOPOULOS, ANGELIKE · 2007 to 2016
$3.0M
REGULATION OF MESODERM DEVELOPMENTR01HD030832 · NICHD · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI FRASCH, MANFRED · 1994 to 2008
$2.8M
NICHD NIH HHS NIH HD30832/HD/NICHDNICHD NIH HHS R01 HD030832NIGMS NIH HHS NIH GM077668NIGMS NIH HHS R01 GM077668
6 · The paper itself

Abstract

The NK homeodomain factor Tinman is a crucial regulator of early mesoderm patterning and, together with the GATA factor Pannier and the Dorsocross T-box factors, serves as one of the key cardiogenic factors during specification and differentiation of heart cells. Although the basic framework of regulatory interactions driving heart development has been worked out, only about a dozen genes involved in heart development have been designated as direct Tinman target genes to date, and detailed information about the functional architectures of their cardiac enhancers is lacking. We have used immunoprecipitation of chromatin (ChIP) from embryos at two different stages of early cardiogenesis to obtain a global overview of the sequences bound by Tinman in vivo and their linked genes. Our data from the analysis of ~50 sequences with high Tinman occupancy show that the majority of such sequences act as enhancers in various mesodermal tissues in which Tinman is active. All of the dorsal mesodermal and cardiac enhancers, but not some of the others, require tinman function. The cardiac enhancers feature diverse arrangements of binding motifs for Tinman, Pannier, and Dorsocross. By employing these cardiac and non-cardiac enhancers in machine learning approaches, we identify a novel motif, termed CEE, as a classifier for cardiac enhancers. In vivo assays for the requirement of the binding motifs of Tinman, Pannier, and Dorsocross, as well as the CEE motifs in a set of cardiac enhancers, show that the Tinman sites are essential in all but one of the tested enhancers; although on occasion they can be functionally redundant with Dorsocross sites. The enhancers differ widely with respect to their requirement for Pannier, Dorsocross, and CEE sites, which we ascribe to their different position in the regulatory circuitry, their distinct temporal and spatial activities during cardiogenesis, and functional redundancies among different factor binding sites.

Indexed as

Binding SitesDrosophila melanogasterDrosophila ProteinsMyocardiumRepressor ProteinsTrans-ActivatorsAnimalsBase SequenceDNA-Binding ProteinsEnhancer Elements, GeneticGene Expression Regulation, DevelopmentalGenome, InsectHeartMesodermTranscription FactorsDNA-Binding ProteinsDoc1 protein, DrosophilaDrosophila Proteinspnr protein, DrosophilaRepressor Proteinstin protein, DrosophilaTrans-ActivatorsTranscription Factors

Identifiers

PMID23326246
PMCPMC3542182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.